Supplement Aims and Scope
Non-invasive vascular imaging § § Non-invasive assessment of vascular and entothelial § § function Radionuclide Imaging § § Molecular imaging § § Intravascular ultrasound § § Optical coherence tomography § § Article types include original clinical and basic research articles, case reports, commentaries, meeting reports, methodology, perspective, research proposal, reviews, software/ database reviews, and technical advance.
Cardiovascular Imaging: Current Developments in Research and Clinical Practice
This supplement aims to provide readers with a comprehensive overview of current developments in this important area. Topics addressed span non-invasive and invasive cardiovascular imaging and include but are not limited to advances in applied (translational) research in: Echocardiography § § Cardiac computer tomography § § Cardiac MRI and spectroscopy § § Magnetic resonance angiography § § Cardiac positron emission tomography § § T he field of cardiovascular imaging has experienced exponential growth over the past 25 years in terms of new modalities, improvements in the accuracy of these modalities, volume of imaging procedures, technological advancements, and new applications for cardiovascular imaging. As a result, related quality improvement and clinical awareness in this expanding field is essential for researchers and practicing clinicians alike. Technological developments in cardiovascular imaging have affected every aspect of practice leading to noticeable improvements in diagnosis and impact on patient management. Our supplement highlights the major advances in many of the current areas of cardiovascular imaging and the expanding clinical applications of these imaging modalities including echocardiography, cardiac CT imaging, perfusion imaging and others.
Our supplement addresses many of the facets of cardiovascular imaging and examines new applications in clinical practice. We examine multi-detector coronary CT (MDCT) imaging for the identification of coronary artery stenoses in a "Real-World" population and highlight the fact that coronary CTA has become an essential and central tool in the assessment for coronary artery disease (CAD). We further document that MDCT is an accurate imaging tool that allows a non-invasive assessment of significant CAD with a high diagnostic accuracy in a "real-world" population of patients. The sensitivity and specificity that we noted are not as high as those in prior reports of idealized selected patients, but are more indicative of an "unselected" real world population. 1 The paper by Catanzaro and colleagues 2 goes on to further document the usefulness of MDCT in the planning and guidance of cardiac resynchronization therapy-lead implantation by evaluating the coronary venous anatomy with MDCT. This study demonstrates the capacity of MDCT to delineate large venous structures as well as the ability to characterize the environment through which the LV lead must be advanced to achieve optimal LV pacing. Furthermore, it shows that MDCT can be used to reconstruct coronary venous structures with accurate fidelity compared to intracoronary venograms. This ability to predict availability of appropriate target vessels is an additional utility of MDCT scanning prior to CRT implantation. 2 Cardiovascular imaging improvements have allowed us to better understand the pathophysiology underlying heart disease. This is documented in the article in the supplement assessing gender difference in coronary calcification as assessed by MDCT. Documentation of clear differences between males and females regarding total vessel calcium scores and therefore risk of future adverse coronary events is noted in this work. Males tended to have higher average calcium scores in each coronary artery than females with a greater tendency to have multiple vessel involvement. Using this information, more large-scale, randomized controlled studies should be performed to correlate differences in the extent of coronary calcification with the observed variance in clinical presentation during coronary events between males and females as a means to potentially establish gender-specific therapeutic regimens. These noted differences may point to the answer and cause for observed presentation variations with respect to cardiac disease in men versus women. 3 The supplement also highlights the essential nature of one of the cardiology field's most accessible and commonly used imaging modalities: echocardiography. Echocardiographic indices have been used as predictors of prognosis and outcomes. For example, the determination of echocardiographic parameters that can be used to reliably assess the risk of the development of life-threatening ventricular arrhythmias (VA) can theoretically improve outcomes by guiding alterations in either pharmacologic or electrophysiologic therapy and in risk stratification prior to consideration for ICD implantation. The study in our supplement that demonstrates the main echocardiographic predictors associated with the first occurrence of VA may provide the impetus for more large-scale studies evaluating the utility of readily available echocardiographic parameters as predictors of ventricular arrhythmias. 4 Another report 5 highlights the importance of echocardiography in the identification and evaluation of anatomical findings noted on imaging studies.
In a recent commentary, 6,7 the future of cardiovascular imaging is summarized by citing the following eight opportunities and challenges: "1) Imaging is crucial in cardiovascular health care delivery. 2) Multimodality imaging ranges from high-end, molecular imaging to hand-held devices.
3 6, 7 It is clear that cardiovascular imaging will always be an integral part of the practice and delivery of cardiovascular medicine. Emphasis must be placed on appropriate utilization of technology and resources and application of quality and safety techniques to assure adequate use and delivery of benefit. With this in mind, the future and current state of cardiovascular imaging is strong and will continue to grow and be an integral part of daily clinical practice for the management of the cardiovascular patient. 
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